Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W G Newman

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
British Journal of Cancer|July 28, 2010
Understanding chemotherapy treatment pathways of advanced colorectal cancer patients to inform an economic evaluation in the United KingdomF H Shabaruddin, R A Elliott, J W Valle, et al.
Frontiers in Pediatrics|November 13, 2024
A national survey of first line antibiotic use in neonatal units - and the potential scope for iatrogenic sensorineural hearing loss preventionJ Peterson, L Muddiman, F Groves, et al.
Scandinavian Journal of Rheumatology|August 31, 2016
A synonymous variant in TREX1 is associated with systemic sclerosis and severe digital ischaemiaM Hughes, J Little, A L Herrick, et al.
Clinical Genetics|October 12, 2012
Is multiple SNP testing in BRCA2 and BRCA1 female carriers ready for use in clinical practice? Results from a large Genetic Centre in the UKS L Ingham, J Warwick, H Byers, et al.
Clinical Genetics|April 20, 2018
A known pathogenic variant in the essential mitochondrial translation gene RMND1 causes a Perrault-like syndrome with renal defectsL A M Demain, D Antunes, J O'Sullivan, et al.
Familial Cancer|May 27, 2010
Breast cancer susceptibility variants alter risk in familial ovarian cancerA Latif, H J McBurney, S A Roberts, et al.
QJM : Monthly Journal of the Association of Physicians|June 4, 2020
Utilizing point-of-care diagnostics to minimize nosocomial infection in the 2019 novel coronavirus (SARS-CoV-2) pandemicJ H McDermott, D Stoddard, J M Ellingford, et al.
Clinical Genetics|February 21, 2007
Array comparative genomic hybridization for diagnosis of developmental delay: an exploratory cost-consequences analysisW G Newman, S Hamilton, J Ayres, et al.
Familial Cancer|April 3, 2010
RASSF1A polymorphism in familial breast cancerJ Bergqvist, A Latif, S A Roberts, et al.
Journal of Medical Genetics|June 5, 2015
The BRCA2 polymorphic stop codon: stuff or nonsense?J E Higgs, E F Harkness, N L Bowers, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
British Journal of Cancer|July 28, 2010
Understanding chemotherapy treatment pathways of advanced colorectal cancer patients to inform an economic evaluation in the United KingdomF H Shabaruddin, R A Elliott, J W Valle, et al.
Frontiers in Pediatrics|November 13, 2024
A national survey of first line antibiotic use in neonatal units - and the potential scope for iatrogenic sensorineural hearing loss preventionJ Peterson, L Muddiman, F Groves, et al.
Scandinavian Journal of Rheumatology|August 31, 2016
A synonymous variant in TREX1 is associated with systemic sclerosis and severe digital ischaemiaM Hughes, J Little, A L Herrick, et al.
Clinical Genetics|October 12, 2012
Is multiple SNP testing in BRCA2 and BRCA1 female carriers ready for use in clinical practice? Results from a large Genetic Centre in the UKS L Ingham, J Warwick, H Byers, et al.
Clinical Genetics|April 20, 2018
A known pathogenic variant in the essential mitochondrial translation gene RMND1 causes a Perrault-like syndrome with renal defectsL A M Demain, D Antunes, J O'Sullivan, et al.
Familial Cancer|May 27, 2010
Breast cancer susceptibility variants alter risk in familial ovarian cancerA Latif, H J McBurney, S A Roberts, et al.
QJM : Monthly Journal of the Association of Physicians|June 4, 2020
Utilizing point-of-care diagnostics to minimize nosocomial infection in the 2019 novel coronavirus (SARS-CoV-2) pandemicJ H McDermott, D Stoddard, J M Ellingford, et al.
Clinical Genetics|February 21, 2007
Array comparative genomic hybridization for diagnosis of developmental delay: an exploratory cost-consequences analysisW G Newman, S Hamilton, J Ayres, et al.
Familial Cancer|April 3, 2010
RASSF1A polymorphism in familial breast cancerJ Bergqvist, A Latif, S A Roberts, et al.
Journal of Medical Genetics|June 5, 2015
The BRCA2 polymorphic stop codon: stuff or nonsense?J E Higgs, E F Harkness, N L Bowers, et al.
Pageof 3